SEC Form 4 · accession 0001209191-18-064128
Cue Biopharma, Inc. · CUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anish Suri
Officer — Chief Scientific Officer
Period of report
Dec 21, 2018
Accepted (ET)
Dec 26, 2018 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645460
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2018 | P | 2,000 | $4.37 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.